Publications - Acaster Lloyd Consulting Ltd

Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency

Acaster, S., Williams, K., Skrobanski, H., Buesch, K. (2022). Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency. Future Neurology, 17, 2.

Symptoms and impacts of aromatic L-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function

Williams K., Skrobanski, H., Buesch, K., Acaster, S. (2022). Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function. Orphanet J Rare Dis, 17: 128.

Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers

Gallop, K. Acaster, S., de Vries, J., Browne, R., Ryan, R., Bker, S., Du Toit, G. (2022). Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers. Patient Preference and Adherence, 16, 1269-1278.

Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom

Lo, SH., Gorni, K., Sutherland, CS., Marti, Y., Lloyd, AJ., Paracha, N. (2022). Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Pharmacoeconomics, 40, 91-102.

Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries

Lo, SH., Lawrence, C., Gorni, K., Sutherland, CS., Marti, Y., Lloyd, AJ., Paracha, N. (2022). Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Pharmacoeconomics, 40, 91-102.

Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States

Lo, SH., Lloyd, AJ., Elkhalifa, S., Sisic, Z., van Nooten, FE. (2022). Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States. Pharmacoeconomics Open, 6, 231-239.

Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex

Lo, SH., Marshall, J., Skrobanski, H., Lloyd, A. (2022). Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex. Pharmacoeconomics Open, 6, 105-121.

Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model

Williams K., Davidson, I., Rance, M., Boehnke, A., Buesch, K., Acaster, S. (2021). Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model. Journal of Patient-Reported Outcomes.

The EQ-5D and the EuroQol Group

Lloyd AJ & Pickard SA. (2019). Value in Health, 22(1), 21-22.

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Brazier J, Ara R, Azzabi I ... Lloyd AJ, Paisley MA & Pickard SA. (2019). Value in Health, 22(3), 267-275.

Patient reported outcome and observer reported outcome assessment in rare disease trials

Acaster, S. (2017) Value in Health, 20(7)

A novel patient-derived conceptual model of the impact of coeliac disease in adults: Implications for patient-reported outcome and health-related quality of life instrument development

Leffler D, Acaster S, Gallop K, Dennis M, Adelman D. (2017) Value in Health

Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment

Lloyd AJ, Gallop K, Ali S, Hughes D & MacCulloch A. (2017) Current medical research and opinion, 33(1), 23-29

Special Edition on Utility Measurement

Lloyd, AJ PharmacoEconomics (2017). 35(Suppl 1): 5

EQ-5D: Moving from Three Levels to Five

Lloyd AJ Value Health 2018 21, 57–58

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_160288895_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.